Article
Dallas—Essilor will acquire Johnson & Johnson Vision Care Inc.'s Spectacle Lens Group, including the group's Definity brand of progressive lenses.
Faster identification of infants at high risk of ROP by evaluating the effects of maternal and fetal vascular malperfusion
ROP: Treating and preventing blindness in preterm babies
Early-onset sepsis may be a risk factor for ROP
Managing a changing landscape of IRD pediatric cases
Prevent Blindness unveils Children’s Vision Health Map, corresponding report
Prevent Blindness kicks off World Sight Day activities with congressional briefing on Capitol Hill, partnerships and vision screening events nationwide